SCHEMBL7576844

SCHEMBL7576844

O=C(O)C(Nc1cc(Cl)cc(Cl)c1)c1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
KDM4E B2RXH2 1/20 0.54
KMT2A Q03164 5/20 0.50
MEN1 O00255 4/20 0.50
MAPT P10636 2/20 0.50
GAA P10253 1/20 0.50
RAB9A P51151 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
LMNA P02545 1/20 0.46
TACR1 P25103 1/20 0.44
EGFR P00533 1/20 0.43
KEAP1 Q14145 1/20 0.42
NFE2L2 Q16236 1/20 0.42
DHODH Q02127 1/20 0.42
FPR2 P25090 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2639604 0.87 NPC1 (0.54) ALDH1A1SMN1; SMN2KDM4EKMT2AMEN1
SCHEMBL7584713 0.86 CA1 (0.44) ALDH1A1SMN1; SMN2KDM4EKMT2AMEN1
SCHEMBL1696047 0.84 MDM2 (0.48) ALDH1A1SMN1; SMN2KDM4EKMT2AMEN1
SCHEMBL4856820 0.82 ALDH1A1 (0.43) ALDH1A1SMN1; SMN2KDM4EKMT2AMEN1
SCHEMBL7584703 0.81 NPC1 (0.53) ALDH1A1SMN1; SMN2KDM4EKMT2AMEN1
SCHEMBL7574221 0.81 ALDH1A1 (0.44) ALDH1A1SMN1; SMN2KDM4EKMT2AMEN1
SCHEMBL2483521 0.81 FPR2 (0.49) ALDH1A1SMN1; SMN2KDM4EMAPTLMNA
SCHEMBL146704 0.81 FPR2 (0.49) ALDH1A1SMN1; SMN2KDM4EMAPTLMNA
SCHEMBL2483519 0.81 FPR2 (0.49) ALDH1A1SMN1; SMN2KDM4EMAPTLMNA
SCHEMBL7576130 0.81 NPC1 (0.56) ALDH1A1SMN1; SMN2KDM4EKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1242069-A2 ALBUMIN-BINDING COMPOUNDS THAT PREVENT NONENZYMATIC GLYCATION AND THAT MAY BE USED FOR TREATMENT OF GLYCATION-RELATED PATHOLOGIES EXOCELL, INC. (US) 2002-09-25 EP disclosed
WO-2001003684-A2 ALBUMIN-BINDING COMPOUNDS THAT PREVENT NONENZYMATIC GLYCATION AND THAT MAY BE USED FOR TREATMENT OF GLYCATION-RELATED PATHOLOGIES EXOCELL, INC. (US) 2001-01-18 WO disclosed